{
  "id": "nclex_ngn_aki_safety_001",
  "type": "orderedResponse",
  "stem": "The nurse is caring for a client admitted with acute kidney injury (AKI). After reviewing the newly available data in the electronic health record (EHR), the nurse must determine the priority of actions. Drag and drop the actions into the correct order, from highest priority to lowest priority.",
  "prompt": "The nurse assumes care for a 68-year-old male client on the medical-surgical unit. The client has a history of hypertension and type 2 diabetes mellitus. The nurse reviews the client's electronic health record (EHR).",
  "exhibits": [
    {
      "id": "EHR_NursesNotes",
      "type": "EHR",
      "label": "Nurses' Notes",
      "content": "Client admitted from the Emergency Department (ED) 1 hour ago with a diagnosis of Acute Kidney Injury (AKI), likely secondary to dehydration from a viral illness. Client reports feeling weak and nauseous for 3 days with minimal oral intake and decreased urine output. He states he delayed seeking care because he is the sole caregiver for his wife who has dementia and has no one to arrange transportation. Client appears fatigued but is alert and oriented x4. Abdomen is soft, non-tender, with hypoactive bowel sounds. 2+ pitting edema noted in lower extremities."
    },
    {
      "id": "EHR_VitalSigns",
      "type": "EHR",
      "label": "Vital Signs",
      "content": [
        {
          "Time": "0800",
          "HR": "98",
          "BP": "142/88",
          "RR": "18",
          "SpO2": "97% on RA",
          "Temp": "37.1°C (98.8°F)"
        },
        {
          "Time": "1200",
          "HR": "104",
          "BP": "150/92",
          "RR": "20",
          "SpO2": "96% on RA",
          "Temp": "37.2°C (99.0°F)"
        }
      ]
    },
    {
      "id": "EHR_Labs",
      "type": "EHR",
      "label": "Laboratory Results",
      "content": [
        {
          "Lab": "Potassium",
          "Value": "6.8 mEq/L",
          "Reference": "3.5-5.0 mEq/L"
        },
        {
          "Lab": "BUN",
          "Value": "88 mg/dL",
          "Reference": "10-20 mg/dL"
        },
        {
          "Lab": "Creatinine",
          "Value": "4.9 mg/dL",
          "Reference": "0.6-1.2 mg/dL"
        },
        {
          "Lab": "Troponin I",
          "Value": "<0.04 ng/mL",
          "Reference": "<0.04 ng/mL"
        },
        {
          "Lab": "Lactate",
          "Value": "1.1 mmol/L",
          "Reference": "0.5-2.2 mmol/L"
        }
      ]
    },
    {
      "id": "EHR_Diagnostics",
      "type": "EHR",
      "label": "Diagnostic Results",
      "content": "**12-Lead ECG Interpretation (1215):**\nSinus tachycardia with tall, peaked T-waves. No ST segment changes noted."
    },
    {
      "id": "EHR_MAR",
      "type": "EHR",
      "label": "Medication Administration Record",
      "content": [
        {
          "Medication": "Lisinopril 10 mg PO",
          "Route": "Oral",
          "Frequency": "Daily",
          "TimeDue": "1300"
        },
        {
          "Medication": "Insulin Glargine 20 units SubQ",
          "Route": "Subcutaneous",
          "Frequency": "Daily",
          "TimeDue": "2100"
        },
        {
          "Medication": "0.9% Sodium Chloride IV",
          "Route": "Intravenous",
          "Frequency": "100 mL/hr",
          "TimeDue": "Continuous"
        }
      ]
    }
  ],
  "options": [
    {
      "id": "opt_3",
      "content": "Notify the healthcare provider of the critical lab and ECG findings."
    },
    {
      "id": "opt_1",
      "content": "Place the client on a continuous cardiac monitor."
    },
    {
      "id": "opt_2",
      "content": "Withhold the scheduled dose of lisinopril."
    },
    {
      "id": "opt_5",
      "content": "Prepare to administer IV regular insulin and 50% dextrose."
    },
    {
      "id": "opt_4",
      "content": "Administer IV calcium gluconate per standing order for hyperkalemia."
    }
  ],
  "answer": [
    "opt_1",
    "opt_4",
    "opt_3",
    "opt_5",
    "opt_2"
  ],
  "rationale": {
    "correct": "The client is experiencing severe hyperkalemia (6.8 mEq/L) secondary to acute kidney injury (AKI), which is a life-threatening emergency. The elevated potassium is due to the kidneys' inability to excrete potassium, a common complication of AKI. The ECG confirms cardiac muscle irritability with tall, peaked T-waves, placing the client at imminent risk for lethal arrhythmias (e.g., ventricular tachycardia, ventricular fibrillation, asystole). Hyperkalemia increases the resting membrane potential of cardiac cells, making them more excitable and prone to dysrhythmias. The nurse's priority actions must follow a sequence that first ensures immediate safety and monitoring, then provides the most rapid-acting intervention to stabilize the heart, followed by communication and further corrective actions. Administering the scheduled lisinopril is contraindicated as it can worsen hyperkalemia by inhibiting aldosterone secretion, which would be a critical safety error. Lisinopril, an ACE inhibitor, blocks the conversion of angiotensin I to angiotensin II, leading to decreased aldosterone production. Aldosterone normally promotes potassium excretion by the kidneys.",
    "incorrect": "Any other order of actions fails to prioritize the immediate, life-threatening risk of cardiac arrest. For example, notifying the provider before placing the client on a monitor leaves the client unmonitored during a period of high risk. Withholding the lisinopril is correct, but it is not the first action; it is a 'do not do' action that is prioritized after immediate life-saving interventions. Preparing insulin/dextrose is a corrective action, but it does not stabilize the cardiac membrane as quickly as calcium gluconate.",
    "answerBreakdown": [
      {
        "label": "1",
        "content": "Place the client on a continuous cardiac monitor.",
        "isCorrect": true,
        "justification": "This is the highest priority. The combination of severe hyperkalemia and ECG changes indicates extreme cardiac instability. Continuous monitoring is the fastest and most crucial independent nursing action to detect and respond to a life-threatening arrhythmia. This action addresses immediate safety and assessment. Hyperkalemia can cause a variety of arrhythmias, including sinus bradycardia, sinus arrest, ventricular tachycardia, and ventricular fibrillation. Continuous monitoring allows for immediate detection and intervention."
      },
      {
        "label": "2",
        "content": "Administer IV calcium gluconate per standing order for hyperkalemia.",
        "isCorrect": true,
        "justification": "This is the most critical *intervention*. Calcium gluconate does not lower serum potassium but works immediately to stabilize the cardiac membrane, antagonizing the cardiotoxic effects of potassium and preventing fatal arrhythmias. Calcium gluconate increases the threshold potential, making the cardiac cells less excitable and less likely to depolarize inappropriately. This is the first step in *treating* the life-threat."
      },
      {
        "label": "3",
        "content": "Notify the healthcare provider of the critical lab and ECG findings.",
        "isCorrect": true,
        "justification": "Once immediate safety measures are initiated (monitoring and cardiac stabilization), the nurse must urgently communicate the critical data to the provider. This allows for collaboration and further orders (like insulin/dextrose, Kayexalate, or dialysis) to definitively lower the potassium level. The provider needs to be informed to determine the underlying cause of the AKI and hyperkalemia and to order further treatment."
      },
      {
        "label": "4",
        "content": "Prepare to administer IV regular insulin and 50% dextrose.",
        "isCorrect": true,
        "justification": "This is the next therapeutic step. This combination works by shifting potassium from the extracellular fluid into the intracellular space, thus lowering the serum potassium level. Insulin stimulates the sodium-potassium ATPase pump, which moves potassium into the cells. Dextrose is given to prevent hypoglycemia from the insulin. While essential, it is prioritized after cardiac membrane stabilization because its onset of action is slower (15-30 minutes) than calcium gluconate."
      },
      {
        "label": "5",
        "content": "Withhold the scheduled dose of lisinopril.",
        "isCorrect": true,
        "justification": "This is a critical 'DON'T PROCEED' action. Lisinopril, an ACE inhibitor, can cause or worsen hyperkalemia by blocking the renin-angiotensin-aldosterone system, thereby reducing potassium excretion. ACE inhibitors prevent the conversion of angiotensin I to angiotensin II, leading to decreased aldosterone production. Aldosterone normally promotes potassium excretion by the kidneys. Administering it to a client with a K+ of 6.8 would be a serious medication error. While critical to patient safety, this action is prioritized after the immediate life-saving interventions for the existing hyperkalemia."
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyze",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Reduction of Risk Potential",
    "difficulty": "Level 4-5",
    "topicTags": [
      "Acute Kidney Injury",
      "Hyperkalemia",
      "Medication Safety",
      "Contraindication",
      "Cardiac Arrhythmia",
      "Prioritization"
    ]
  },
  "clinicalPearl": "In hyperkalemia, always prioritize cardiac monitoring and interventions to stabilize the cardiac membrane (e.g., calcium gluconate) before interventions to lower serum potassium. Certain medications, like ACE inhibitors, can exacerbate hyperkalemia and should be held. Remember the mnemonic 'C BIG K Drop' for hyperkalemia treatment: Calcium gluconate, Bicarbonate, Insulin, Glucose, Kayexalate, Dialysis.",
  "sbar": {
    "situation": "At 1230, a 68-year-old male admitted with acute kidney injury (AKI) secondary to dehydration is experiencing severe hyperkalemia. Potassium is 6.8 mEq/L and ECG at 1215 shows sinus tachycardia with peaked T-waves.",
    "background": "The client has a history of hypertension and type 2 diabetes mellitus. He was admitted from the ED approximately 1 hour ago with weakness, nausea, decreased oral intake, and decreased urine output. Lisinopril 10mg PO daily is due at 1300.",
    "assessment": "The client is alert and oriented x4, but fatigued. Vitals at 1200: HR 104, BP 150/92, RR 20, SpO2 96% on RA, Temp 37.2°C. Labs show elevated BUN and creatinine. ECG at 1215 shows sinus tachycardia with tall, peaked T-waves. 2+ pitting edema noted in lower extremities.",
    "recommendation": "I recommend initiating continuous cardiac monitoring immediately, administering IV calcium gluconate per standing order for hyperkalemia, notifying the healthcare provider STAT, preparing to administer IV regular insulin and 50% dextrose, and withholding the scheduled dose of lisinopril at 1300. Further orders may be needed to address the hyperkalemia and AKI."
  },
  "sentinelStatus": "healed_v2026_v8"
}